Tourmaline Bio, Inc.

NASDAQ (USD): Tourmaline Bio, Inc. (TRML)

Last Price

21.84

Today's Change

+0.445 (2.07%)

Day's Change

21.01 - 21.86

Trading Volume

88,466

Overview

Market Cap

560 Million

Shares Outstanding

25 Million

Avg Volume

221,137

Avg Price (50 Days)

25.25

Avg Price (200 Days)

20.29

PE Ratio

-8.77

EPS

-2.49

Earnings Announcement

17-Mar-2025

Previous Close

21.39

Open

21.17

Day's Range

21.0139 - 21.86

Year Range

12.12 - 48.31

Trading Volume

89,957

Price Change Highlight

1 Day Change

2.08%

5 Day Change

8.01%

1 Month Change

-8.31%

3 Month Change

-12.11%

6 Month Change

55.44%

Ytd Change

-17.58%

1 Year Change

-20.50%

3 Year Change

-85.03%

5 Year Change

-86.56%

10 Year Change

-86.56%

Max Change

-86.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED). The company was incorporated in 2021 and is based in New York, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment